Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience.
Akihiro UchiikeHaruka KonoKatsuhiro MiuraTatsuya HayamaDaisuke TsutsumiShinya TsuboiSusumu OhtsukaShinji HidakaPublished in: Journal of pharmaceutical health care and sciences (2023)
Our study results support the clinical application of olanzapine for the secondary prevention of breakthrough CINV.
Keyphrases